Zydus Lifesciences has informed that ESG Risk Assessments and Insights (‘ESGRAIL’), a SEBI registered ESG Rating Provider has assigned overall ESG rating of 68 (last year 66) to the Company. The report was received by way of an email on April 9, 2026, at 15:30 hours. The Company had not engaged ESGRAIL for the ESG Rating. ESGRAIL has independently prepared the report based on publicly available information. This disclosure is made in compliance with the provisions of regulation 30 of the Listing Regulations read with the SEBI Circular.
The above information is a part of company’s filings submitted to BSE.
